Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Induction of tubulin by Docetaxel is associated with p53 status in human non small cell lung cancer cell lines
 
  • Details
Options

Induction of tubulin by Docetaxel is associated with p53 status in human non small cell lung cancer cell lines

Journal
International Journal of Cancer
Date Issued
2006-01-15
Author(s)
JINGHUA TSAI CHANG  
GEE-CHEN CHANG  
JIUNN-LIANG KO  
DOI
10.1002/ijc.21372
URI
https://www.scopus.com/pages/publications/28844483319
https://scholars.csmu.edu.tw/handle/123456789/22577
Abstract
Docetaxel (DOC), a member of the taxane family of anticancer drugs, binds to tubulin and produces unnaturally stable microtubules that induce cell death. DOC is used clinically alone or in combination with other compounds to treat advanced stages of cancer. We have treated the human lung cancer cell lines A549 and H1299 and human cervical cancer HeLa cells with low concentrations of DOC to characterize the response of β-tubulin isotypes and p53 genes. The relationship between p53 function and DOC, acting through a microtubule-based mechanism, was examined. We found that after 18-hr treatment with DOC, β-tubulin gene transcription was enhanced in p53-null H1299 cells but not in A549 cells. Also, p53 RNA was strongly induced in the A549 cells. In addition, β-tubulin levels also increased in the H1299 cells after the DOC treatment. Further demonstrating an association of DOC treatment with p53 and β-tubulin, inhibition of p53 expression by interference RNA in A549 cells showed increasing β-tubulin gene expression with DOC treatment. We also selected a clone from the H1299 cells that stably expressed p53, examined the β-tubulin expression after DOC treatment and found an inhibition of β-tubulin induction in these p53-expressing cells. Our data suggest that the initial response of cells to DOC treatment involves p53; alternatively, in the absence of p53, tubulins may be transactivated. Selection of the DOC-resistant A549 cells showed β-tubulin expression was increased, in contrast to the initial response to the DOC treatment. From the initial and selection responses of β-tubulin in cancer cells, it appears that there is a p53-associated β-tubulin expression as a result of the DOC treatment.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback